PROVIDER PROFILE · NPI 1174726954

Roslyn Chaisanguanthum

MEDICARE UTILIZATION · PART B · 2024

No data available for this provider in 2024.

PRESCRIBING · PART D · 2024

Total Rx claims

1,090

Beneficiaries

—

Total drug cost

$3.3M

Distinct drugs

Brand share

23.2%

Top prescribed drugs

Letrozole256 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

FACILITY AFFILIATIONS

Hospital & Facility Affiliations (1)

Hospital

CROSS-REFERENCE